1. MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer
- Author
-
Jintong Ji, Han Shengbo, Xiaogang Shu, Zili Zhou, Liang Wu, Bao Haijun, Zhang Xudan, Wenzheng Yuan, Zhao Ning, Liu Zhengyi, and Jinhuang Chen
- Subjects
Male ,Aging ,Colorectal cancer ,proliferation ,colorectal cancer ,Biology ,Metastasis ,Cell Line, Tumor ,microRNA ,medicine ,Gene silencing ,Humans ,metastasis ,Cytoskeleton ,Gene ,miR-214-3p ,Aged ,Cell Proliferation ,Tumor size ,Myosin Heavy Chains ,RNA-Binding Proteins ,Cell Biology ,Middle Aged ,medicine.disease ,HCT116 Cells ,digestive system diseases ,DNA-Binding Proteins ,MicroRNAs ,Cancer research ,Female ,PLAGL2 ,Colorectal Neoplasms ,Chromatin immunoprecipitation ,Signal Transduction ,Transcription Factors ,Research Paper - Abstract
Evidence has shown that microRNAs (miRNAs) participate in the progression of CRC. Previous studies have indicated that miR-214-3p is abnormally expressed in various malignant tumors. However, the biological function it plays in CRC and the potential mechanism are unclear. Here, we demonstrated that miR-214-3p was obviously downregulated in CRC. Moreover, we found a strong correlation between the miR-214-3p level and tumor size and lymphatic metastasis. Furthermore, when miR-214-3p was decreased by an Lv-miR-214-3p inhibitor, the proliferation and migration of SW480 and HCT116 cells were significantly increased. As expected, the ability of proliferation and migration was significantly suppressed when miR-214-3p was overexpressed in DLD1 cells. According to the dual-luciferase reporter results, PLAGL2 was found to be a direct downstream molecule of miR-214-3p. Chromatin immunoprecipitation (CHIP) confirmed that MYH9, a well-known cytoskeleton molecule in CRC, was a direct targeting gene of PLAGL2. Silencing PLAGL2 or MYH9 could reverse the effect of a miR-214-3p inhibitor on CRC cells. In summary, our studies proved that low expression of miR-214-3p and overexpression of downstream PLAGL2 in CRC indicated a poor prognosis. MiR-214-3p suppressed the malignant behaviors of colorectal cancer by regulating the PLAGL2/MYH9 axis. MiR-214-3p might be a novel therapeutic target or prognostic marker for CRC.
- Published
- 2019